Literature DB >> 19609311

Keratin K6c mutations cause focal palmoplantar keratoderma.

Neil J Wilson1, Andrew G Messenger, Sancy A Leachman, Edel A O'Toole, E Birgitte Lane, W H Irwin McLean, Frances J D Smith.   

Abstract

The palmoplantar keratodermas (PPKs) are a large group of clinically and genetically heterogeneous genodermatoses. The gene defects underlying many PPKs still need to be resolved to facilitate definitive molecular diagnosis and genetic counseling. Dominant-negative mutations in any of the four identified keratin genes, KRT6A, KRT6B, KRT16, or KRT17, cause pachyonychia congenita (PC), characterized by hypertrophic nail dystrophy and other ectodermal features. In PC, focal PPK (FPPK) is the most painful and debilitating phenotypic feature. Some families presenting with FPPK alone, or with minimal nail changes, carry mutations in KRT16; however, most FPPK families do not harbor mutations in any of these keratin genes. Here, we report three unrelated families who presented with familial FPPK with minor or absent nail changes. The four PC/FPPK-related keratin genes were excluded; however, mutational analysis of the recently identified KRT6C gene, encoding keratin K6c, showed heterozygous in-frame deletion mutations in all three kindreds. Affected members of Families 1 and 2 carried the same mutation, p.Asn172del. In Family 3, the mutation p.Ile462-Glu470del co-segregated with the disease. KRT6C was shown to be expressed in the plantar epidermis using reverse transcription-PCR, consistent with the phenotype observed in this tissue. These data expand the genetic testing repertoire for the PPKs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19609311     DOI: 10.1038/jid.2009.215

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.

Authors:  Hai-Bo Hu; Xiao-Ping Yang; Pei-Xia Zhou; Xin-Ai Yang; Bin Yin
Journal:  Genes Genomics       Date:  2019-11-25       Impact factor: 1.839

2.  Altered keratinocyte differentiation is an early driver of keratin mutation-based palmoplantar keratoderma.

Authors:  Abigail G Zieman; Brian G Poll; Jingqun Ma; Pierre A Coulombe
Journal:  Hum Mol Genet       Date:  2019-07-01       Impact factor: 6.150

Review 3.  Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: new insights into skin epithelial homeostasis and avenues for treatment.

Authors:  A G Zieman; P A Coulombe
Journal:  Br J Dermatol       Date:  2019-07-24       Impact factor: 9.302

4.  The molecular genetic analysis of the expanding pachyonychia congenita case collection.

Authors:  N J Wilson; E A O'Toole; L M Milstone; C D Hansen; A A Shepherd; E Al-Asadi; M E Schwartz; W H I McLean; E Sprecher; F J D Smith
Journal:  Br J Dermatol       Date:  2014-08-06       Impact factor: 9.302

5.  A DSG1 Frameshift Variant in a Rottweiler Dog with Footpad Hyperkeratosis.

Authors:  Katherine A Backel; Sarah Kiener; Vidhya Jagannathan; Margret L Casal; Tosso Leeb; Elizabeth A Mauldin
Journal:  Genes (Basel)       Date:  2020-04-24       Impact factor: 4.096

6.  Keratin 16-null mice develop palmoplantar keratoderma, a hallmark feature of pachyonychia congenita and related disorders.

Authors:  Juliane C Lessard; Pierre A Coulombe
Journal:  J Invest Dermatol       Date:  2012-02-16       Impact factor: 8.551

Review 7.  Diagnosis and Management of Inherited Palmoplantar Keratodermas.

Authors:  Bjorn R Thomas; Edel A O'Toole
Journal:  Acta Derm Venereol       Date:  2020-03-25       Impact factor: 3.875

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.